Stockreport

Invivyd to Participate at H.C. Wainwright’s BioConnect Investor Conference

Invivyd, Inc.  (IVVD) 
PDF WALTHAM, Mass., April 25, 2023 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) a clinical-stage biopharmaceutical company on a mission to protect the vulnerable from [Read more]